Home
Home » companies

Takeda

Astellas forecasts big sales growth as prostate drug catches hold

Astellas forecasts big sales growth as prostate drug catches hold
Fierce Pharma

Takeda forecasts 28% slide in profit on weak sales

Takeda forecasts 28% slide in profit on weak sales
Marketwatch

Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out

Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
Bloomberg

Jury hits Takeda with $6.5M judgment in first Actos liability case

Jury hits Takeda with $6.5M judgment in first Actos liability case
Fierce Pharma

Takeda in more trouble at home over recall of mislabeled vials

Takeda in more trouble at home over recall of mislabeled vials
Fierce Pharma

FDA saw early reports of severe Omontys reactions: WSJ

FDA saw early reports of severe Omontys reactions: WSJ
Fierce Pharma

Takeda seeks Japanese approval for brentuximab vedotin to treat relapsed/refractory CD30 positive HL and ALCL

Takeda seeks Japanese approval for brentuximab vedotin to treat relapsed/refractory CD30 positive HL and ALCL
Pharmabiz

Takeda launches Takeda Ecuador

Takeda launches Takeda Ecuador
Pharma Times, UK

Affymax Will Rise Again

Affymax Will Rise Again
Seeking Alpha

NPS Buys Back Rights to Gattex From Takeda to Spur Sales

NPS Buys Back Rights to Gattex From Takeda to Spur Sales
Bloomberg